Rockefeller Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Rockefeller Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35	Closed	-$1.21K	–	4733
2025 Q3	$1.21K	Buy	+35	New	+$1.12K	﹤0.01%	4162
2023 Q1	–	Sell	-265	Closed	-$11K	–	2747
2022 Q4	$11K	Buy	+265	New	+$11.2K	﹤0.01%	3036
2021 Q3	–	Sell	-5	Closed	–	–	3738
2021 Q2	$0	Sell	5 -1	-17%	-$76	﹤0.01%	3499
2021 Q1	$0	Buy	+6	New	+$553	﹤0.01%	3296
2020 Q4	–	Sell	-90	Closed	-$12K	–	2909
2020 Q3	$12K	Buy	+90	New	+$15K	﹤0.01%	1961

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rockefeller Capital Management's LKFT Position: Q4 2025 in Review

Rockefeller Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 35 shares — an estimated $1.21K sold.

Rockefeller Capital Management first reported a position in LKFT in Q3 2020 and held it in 5 quarters. The position peaked at $12K in Q3 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

Rockefeller Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
Rockefeller Capital Management sold 35 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $1.21K.
Rockefeller Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2020 and held it in 5 quarters.
Rockefeller Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $12K in Q3 2020.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Rockefeller Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.